Sandbox reserved 392: Difference between revisions

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

@@ Line 3: / Line 3: @@
 ==Possible Acetylation of Tobramycin CoA Complex by Mycobacterium Tuberculosis==
-==Your Heading Here (maybe something like 'Structure')==<StructureSection load='1dq8' size='500' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1dq8]])' scene=''></StructureSection>
 The study where this molecule was obtained was named "Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis-Complex with Coenzyme A and Tobramycin". The study showed that there might be possible resistance to Tobramycin. The resistance is due to the possible acetylation of Tobramycin by the mycobacteria. When Tobramycin is acetylation it loses its function. The reason for the acetylation is not fully understood but a possible explanation may be that the mycobacteria needs to acetylate so that a key biosynthetic intermediate responsible for reducing, Mycothiol. Mycothiol is a major reducing agent in the myobacteria.
@@ Line 54: / Line 53: @@
 Wikipedia. N.p., n.d. Web. 23 Sept. 2012. <http://en.wikipedia.org/wiki/Redox>
 Wikipedia. N.p., n.d. Web. 23 Sept. 2012. <http://en.wikipedia.org/wiki/Tobramycin>
-</StructureSection>